GlassScriptPhysician profile
Kevin B Karikomi
NPI 1376558932
$13,373.18
in general payments reported to CMS, 2019-2025
42 companies · $2,702 in 2025
The $2,702 reported for 2025 was more than what 83% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,312 · 2020: $1,369 · 2021: $1,777 · 2022: $1,656 · 2023: $2,308 · 2024: $2,250 · 2025: $2,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,980 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,980.02 |
| Education | $279.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,636.53 | 2019-2025 | |
| Janssen Biotech, INC. | $1,447.25 | 2019-2025 | Tremfya |
| Ucb, INC. | $747.53 | 2019-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $724.20 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $672.89 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $651.92 | 2019-2025 | Absorica Ld, Winlevi, Ilumya |
| Genzyme Corporation | $577.02 | 2019-2025 | |
| Galderma Laboratories, L.P. | $554.82 | 2019-2025 | Oracea, Aklief, Epsolay |
| Leo Pharma INC. | $533.85 | 2019-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $512.01 | 2019-2025 | |
| Pfizer INC. | $479.98 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $437.96 | 2019-2024 | Arazlo, Cabtreo |
| Amgen INC. | $390.70 | 2020-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $353.73 | 2019-2025 | Dupixent, Libtayo |
| Almirall LLC | $274.44 | 2019-2025 | Klisyri, Seysara |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Karikomi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.